Teleflex. has been granted a patent for a method to treat benign prostatic hyperplasia using an extra-urethral implant. The method involves inserting a tubular device to deliver an implant with two ring structures designed to enlarge the prostatic urethra’s lumen, facilitating improved urinary function. GlobalData’s report on Teleflex gives a 360-degree view of the company including its patenting strategy. Buy the report here.
Smarter leaders trust GlobalData
According to GlobalData’s company profile on Teleflex, Non-invasive physiological monitoring was a key innovation area identified from patents. Teleflex's grant share as of June 2024 was 62%. Grant share is based on the ratio of number of grants to total number of patents.
Prostatic urethra implants for treating benign prostatic hyperplasia
The patent US12042372B2 outlines a method for treating benign prostatic hyperplasia (BPH) through the use of an interventional device. This device is inserted longitudinally through the urethra until it reaches the prostatic urethra. The device features a tubular elongate structure that delivers an implant composed of at least two circular ring structures, which are designed to enlarge the lumen of the prostatic urethra. Each ring structure forms less than a full circle, creating a slot opening that is misaligned with adjacent openings. The rings are positioned perpendicularly to the urethra's longitudinal axis and are connected by segments parallel to this axis. After the implant is delivered, the device is retracted, leaving the implant in place.
Further claims detail the characteristics and functionalities of the implant and interventional device. The ring structures are designed to expand radially, and the implant can flex longitudinally while remaining generally coaxial with the urethra's lumen. The implant also serves as a physical barrier to inhibit cell growth that could narrow the urethra. Additional features include the potential for delivering multiple implants, the incorporation of a transurethral imaging device for real-time positioning, and an optics system that may utilize polymeric materials to transmit light. The device may also include optical sensors to track the implant's position during the procedure, enhancing the precision of the treatment for BPH.
To know more about GlobalData’s detailed insights on Teleflex, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.
